Scientists have developed an inexpensive new test that can rapidly diagnose COVID-19 infections, a timely advance that comes as clinicians and public health officials are scrambling to cope with ...

Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic in late 2019, the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone several mutations ...

A coronavirus test that could give results in under an hour has been developed, with the CRISPR-based SARS-CoV-2 DETECTR adding gene-targeting to the methods currently in use to track down COVID-19 ...

In their review paper recently published in the Indian Journal of Clinical Biochemistry, a group of authors discusses currently available and forthcoming CRISPR-based diagnostic assays, as well as the ...

Jackson Ryan was CNET's science editor, and a multiple award-winning one at that. Earlier, he'd been a scientist, but he realized he wasn't very happy sitting at a lab bench all day. Science writing, ...

CRISPR-wielder Mammoth Biosciences will team up with Agilent Technologies to help launch its upcoming COVID-19 diagnostic test, designed to handle more than 4,000 samples per day. Applying the gene ...

Scientists have developed a low-cost swab test that can diagnose COVID-19 infection in about 45 minutes, an advance that may help public health officials scrambling to cope with testing backlogs as ...

Uncertainty and fear about coronavirus’ spread and the course of the illness is causing shockwaves in our daily lives. A simple paper test could provide answers to basic questions and shape a sensible ...

Mammoth Biosciences—the CRISPR-based diagnostics developer whose co-founders include Nobel laureate and genome editing pioneer Jennifer Doudna, PhD—plans to develop, scale-up, and commercialize its ...

A study published in the journal Nature Nanotechnology shows that a low-cost tool, called Subak, is effective at telling when nuclease digestion has occurred, which is when an enzyme called nuclease ...